The company had a good quarter, but some investors found its full-year guidance wanting. The stock market staged a robust recovery on Tuesday, but not every company surged ahead in price. Advancing only cautiously was nuclear engineering specialist BWX Technologies (BWXT 0.93%), which published its latest set of quarterly results after market hours Monday night. The following day, the stock closed 0.9% higher, against the more than 1% rise of the S&P 500 index. A double beat, and double-digit growth For its ...

BWX Technologies, Inc. (NYSE:BWXT) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Chase Jacobson - Vice President of Investor Relations Rex Geveden - President and CEO Robb LeMasters - Senior Vice President and CFO Conference Call Participants Scott Deuschle - Deutsche Bank Rob Labick - CJS Securities Pete Skibitski - Alembic Global Peter Arment - Baird Josh Korn - Barclays Andre Madrid - BTIG Michael Ciarmoli - Truist Securities Ron Epstein - Bank of America Thomas Meric - ...

Our Purpose: We employ nuclear technology to solve some of the world's most important excellence, a strong safety record, and a focus problems Our Mission: We provide safe and effective nuclear solutions for global security, clean Second-Quarter 2024 Earnings energy, environmental remediation, nuclear medicine, and space exploration Call Presentation Commitment to innovation, operational on ensuring the highest ESG standards Reported August 5, 2024 Forward-Looking Statements Disclaimer 2 BWX Technologies, I ...

Table of Contents | --- | --- | |-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________________________________ | | | FORM 10-Q | (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE S ...

BWX Technologies Reports Second Quarter 2024 Results • 2Q24 revenues of $681.5 million (1) • 2Q24 net income of $73.0 million, adjusted EBITDA of $126.2 million • 2Q24 diluted GAAP EPS of $0.79, non-GAAP EPS of $0.82 (1) • BWXT-led JV awarded management and operations contract for the NNSA's Pantex Plant • 2024 non-GAAP EPS guidance revised to $3.10-$3.20 (1) Lynchburg, VA – August 5, 2024 - BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2024 results. A rec ...

BWX Technologies (BWXT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on August 5, 2024, might help the stock move higher if these key numbers are better tha ...

When looking at the last two reports, this supplier of nuclear fuel and components to the U.S. government has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 10.44%, on average, in the last two quarters. Thanks in part to this history, there has been a favorable change in earnings estimates for BWX lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when c ...

The uranium sector plays a crucial role in the global energy market, particularly in nuclear power generation. Uranium stocks represent companies engaged in the exploration, mining, and processing of uranium, as well as those involved in the production of nuclear fuel. As the demand for cleaner energy sources increases, these stocks have gained attention for their role in supporting carbon-neutral energy goals. Cameco (CCJ Stock) In 2024 thus far, shares of CCJ stock moved higher by 24.22%. Moreover, during ...

Financial Performance and Key Metrics - The company reported first quarter revenue of $604 million, representing a 6% organic growth on a consolidated basis, with adjusted EBITDA of $115 million, up 4% year-over-year [63] - Adjusted earnings per share increased by 9% to $0.76 compared to $0.70 in the prior year quarter [36] - The adjusted effective tax rate for the quarter was 22.5%, with expectations for a full-year tax rate of approximately 23.5% [4] Business Line Performance - In commercial operations, revenue grew by 7%, driven by increased field service activity in the commercial nuclear business and robust growth in BWXT medical revenue, leading to an adjusted EBITDA of $14 million, up about $5 million [11] - Government operations saw a revenue increase of 6% to $487 million, driven by higher naval nuclear component production and microreactor volume, partially offset by lower long-lead material procurement [38] - The commercial operations segment is expected to grow in high single digits to low double digits in 2024, with higher EBITDA margins compared to 2023 [40] Market Data and Key Metrics - The company is experiencing strong demand in the commercial nuclear markets, with a backlog of over $700 million and ongoing life extensions of CANDU reactors in Canada [50] - The expansion of the Cambridge facility is expected to enhance the company's position as a leading supplier of large nuclear equipment in North America, particularly for small modular reactors (SMRs) [3][22] - The fiscal year 2025 budget request supports clean energy investments, including advanced nuclear technology development, which is crucial for growth in the micro and small modular reactor markets [8] Company Strategy and Industry Competition - The company is focused on capturing growth opportunities in core businesses, innovating to pursue new markets, and driving operational excellence [69] - Investments in the Cambridge plant are aimed at preparing for anticipated demand in the nuclear sector, particularly for SMRs and naval propulsion [23][50] - The company is positioned to benefit from government support for critical technologies, such as the DRACO project, which could provide a strategic advantage in military applications [28] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year guidance, expecting mid-single-digit revenue and adjusted EBITDA growth, leading to adjusted earnings per share of $3.05 to $3.20 [1][41] - The company remains vigilant regarding labor and supply chain issues but has successfully navigated challenges post-COVID [26] - Management highlighted the importance of maintaining a strong backlog and the strategic priority of the Virginia-class submarine program, despite potential delays in shipbuilding schedules [54][106] Other Important Information - The company is the only commercial supplier of non-carrier-added actinium and plans to ramp up commercial sales of lutetium significantly next year [61] - Capital expenditures for the quarter were $30 million, with expectations for full-year CapEx to be flat to slightly down compared to 2023 [65] - The company is maintaining free cash flow guidance of $225 million to $250 million, driven by EBITDA growth and improved working capital management [80] Q&A Session Summary Question: Update on the drug master file for lutetium - Management indicated that the process for seeking Canadian approval for the irradiation of ytterbium is progressing well, with expectations to be in business on lutetium sometime next year [75][76] Question: Insights on the multi-year pricing negotiation - Management acknowledged delays in the multi-year pricing negotiation due to uncertainties around fiscal year 2024 appropriations but expressed optimism about finalizing the agreement soon [73] Question: Impact of Navy shipbuilding delays - Management noted that while Navy shipbuilding delays could affect schedules, the company is somewhat decoupled from shipyard operations, focusing instead on fulfilling orders for naval reactors [101][106] Question: Updates on the Pickering project - Management confirmed that the Pickering project is significant, with expectations for substantial opportunities related to steam generators and other components [90][113]

First-Quarter 2024 Earnings Call problems energy, environmental remediation, nuclear Commitment to innovation, operational 2 excellence, a strong safety record, and a focus nuclear solutions for global security, clean Presentation Reported May 6, 2024 BWX Technologies, Inc. ("BWXT") cautions that statements in this presentation that are forward-looking and provide other than historical information involve risks and uncertainties that may impact actual results and any future performance suggested in the forw ...